Oxygen Therapy Market Today

Over 4.2 million beds for patients in hospitals, long-term care, nursing homes, and home-care need to be equipped with oxygen in the United States. Oxygen therapy is a prominent therapeutic treatment for patients suffering with Interstitial Lung Disease, COVID, Pulmonary Arterial Hypertension, COPD, and many other life-threatening conditions.

The Urgent Need

Over 20 million people in the world using home supplemental oxygen for a variety of lung conditions resort to regularly removing their nasal cannula to ensure flow of oxygen. Lack of oxygenation can manifest as respiratory distress, cyanosis, rapid onset of fatigue, and problems with memory and concentration. Patients want to retain their mobility while undergoing oxygen therapy. Remote monitoring is of high value to quality of life.

In a recent survey conducted by Jacobs et. Al, oxygen therapy patients report:

Insufficient oxygenation can lead to hypoxia (insufficient tissue oxygenation), hypoxemia (O2 deficiency in arterial blood), and other life-threatening conditions. Patients want to retain their mobility while undergoing oxygen therapy. Remote monitoring is of high value to quality of life.

Advanced Interactive Response Systems (AIRS) was founded to bring needed oxygen monitoring, regulation, data and reporting solutions to the market. 

AIRS produces high-quality safety and monitoring products that improve patient health and care-giver performance.

The AIRS Mission

Since its founding in 2014 and it’s very first patent, AIRS has made great strides in improving 02 therapy better for caregivers and patients. Our mission is to be the leader in technology and quality of care solutions for COPD and O2 therapy patients by partnering with quality organizations and dedicating ourselves to improving the lives of oxygen dependent patients, the institutions and care-givers who rely on O2 therapy.

The AIRS Opportunity